⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer

Official Title: Evaluation of the Efficacy of a Homeopathic Protocol to Reduce the Onset or Aggravation of Joint Pain or Stiffness Following the Taking of Anti-aromatases (AI) in Patients With Non-metastatic Breast Cancer

Study ID: NCT04408560

Study Description

Brief Summary: Interventional, randomised, prospective, monocentric study

Detailed Description: Interventional, randomised, prospective, monocentric study Primary objective : Demonstrate the interest of the homeopathic Protocol to reduce the onset or aggravation of joint pain as a result of the taking of AI compared to conventional care Secondary objective : Compare between the two treatment groups: * Evolution of joint pain * Evolution of joint stiffness-rate of onset of pain and joint stiffness-delay in onset or aggravation of pain-evolution of the number of painful locations-evolution of the impact of pain on the quality of the sleep-consumption of permitted concomitant treatments (analgesics) * Evolution of symptoms of hormonal deprivation-adherence to AI treatment * Tolerance to AI * Change seen by patients * Stop rate and switch of AI-rate of recurrence of breast cancer Describe in patients receiving homeopathic treatment: * Adherence to homeopathic treatment * Tolerance to homeopathic treatment * Group A: Group of patients receiving conventional treatment (drug analgesic class 1) for joint pain + homeopathic treatment * Group B: Group of patients receiving conventional treatment (drug analgesic class 1) for joint pain Schedule : * Inclusions start at: 01/09/2018 * End date of inclusions: 01/09/2021 * End date of follow-up: 23/03/2022 * Study report: 23/03/2023

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Philippe GUILBERT, Reims, , France

Contact Details

Name: PHILIPPE GUILBERT

Affiliation: Institut Jean-Godinot

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: